Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Musculoskeletal safety of prophylactic ciprofloxacin in children with acute lymphoblastic leukemia
NL-OMON50488Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ciprofloxacin in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Erasmus MC. Primary endpoints: Cartilage damage on MRI, Quantitative cartilage quality parameters and 3 more. Started Jul 2014; status: active, not recruiting.
02
Drugs
ciprofloxacin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON50488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50488.